BioNordic A/S: Financial statements 2025
CVR: 40831622
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
BioNordic A/S (CVR 40831622) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 49,188,844 and a net result of DKK 131,702,212 compared with DKK -20,860,483 the year before. That is a decrease of 16.9% compared with the year before. Equity in the 2025 report amounted to DKK 163,782,004. The solvency ratio was 68.5%. The company had 62 employees in the financial year.
- Gross Profit
- DKK 49,188,844
- Profit/Loss
- DKK 131,702,212
- Equity
- DKK 163,782,004
- Total Assets
- DKK 239,170,173
- Employees
- 62
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 49.2M | 131.7M | 163.8M | 62 |
| 2024 | - | 59.2M | -20.9M | 31M | 77 |
| 2023 | - | 95.6M | 24.5M | 48.9M | 83 |
| 2022 | - | 77.8M | 5.2M | 24.8M | 98 |
| 2021 | - | 40.3M | 408K | 18.2M | 84 |
Official annual report
How creditworthy is BioNordic A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
BioNordic A/S has published its annual report for 2024. Gross profit came to DKK 59,211,773, and the net result was DKK -20,860,483.
About BioNordic A/S
BioNordic A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Troels Zakarias Glahn Kristiansen. The board consists of Ole Bødtker Nielsen (chair), Lene Ploug Bülow and Nicolas Bødtker Nielsen. The company's owners include Ole Bødtker Nielsen, Stefan Bødtker Michelsen and Nicolas Bødtker Nielsen. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 49,188,844 and a net result of DKK 131,702,212 compared with DKK -20,860,483 the year before. Equity in the 2025 report amounted to DKK 163,782,004.